Structure-Function of the Cardiac Sodium Channel

心脏钠通道的结构-功能

基本信息

  • 批准号:
    7392179
  • 负责人:
  • 金额:
    $ 36.15万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2000
  • 资助国家:
    美国
  • 起止时间:
    2000-09-29 至 2010-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The central role of Na channels in excitable cells gives it a critical role in normal and abnormal behavior. Its gating is a complex system, and even modest dysfunction of gating results in debilitating disease or death. The long term goal of this proposal is to understand the structure and function of the cardiac Na channel as a key contributor to normal and abnormal excitation and conduction and as a target of drugs to treat arrhythmias. For the first time sufficient information is available that we can hope to connect the action of drugs to limit permeation with their action to affect gating. The goals of the proposal for the next five years are to 1) Identify the conformational changes of S6 segments during activation; 2) Identify conformational changes in S6 during fast inactivation and their relation to S4 movements; 3) Determine the molecular features of local anesthetic drug binding and the mechanism of action; and 4} Locate superficial residues on S6 and S5 helices in relation to S4 segments. The experiments proposed combine molecular techniques with electrophysiology, principally whole cell ionic and gating current recordings, and molecular modeling to identify conformational changes in the inner pore S5 and S6 segments in response to S4 voltage sensor movement and drug binding. A key element of the proposal is to integrate: experimental data, both our own and that of others, into a molecular model of the relationship between < drug binding, gating, and the conformation of the inner pore.
描述(由申请人提供):钠通道在可兴奋细胞中的中心作用使其在正常和异常行为中发挥关键作用。它的门控是一个复杂的系统,即使是轻微的门控功能障碍也会导致衰弱的疾病或死亡。这项提议的长期目标是了解心脏钠通道的结构和功能,它是正常和异常兴奋和传导的关键贡献者,也是治疗心律失常的药物的靶点。这是第一次有足够的信息,我们可以希望将药物限制渗透的作用与它们影响门控的作用联系起来。该提案未来五年的目标是:1)确定S6片段在激活过程中的构象变化;2)确定S6在快速失活过程中的构象变化及其与S4运动的关系;3)确定局部麻醉剂药物结合的分子特征和作用机制;以及4)定位与S4片段相关的S6和S5螺旋上的表面残基。实验提出将分子技术与电生理学,主要是全细胞离子和门控电流记录,以及分子建模相结合,以确定内孔S5和S6片段在S4电压传感器移动和药物结合时的构象变化。该提案的一个关键要素是将我们自己和其他人的实验数据整合到一个分子模型中,该模型描述了药物结合、门控和内孔构象之间的关系。

项目成果

期刊论文数量(14)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Late Na+ current produced by human cardiac Na+ channel isoform Nav1.5 is modulated by its beta1 subunit.
  • DOI:
    10.1007/s12576-009-0029-7
  • 发表时间:
    2009-05
  • 期刊:
  • 影响因子:
    2.3
  • 作者:
    Maltsev, Victor A.;Kyle, John W.;Undrovinas, Albertas
  • 通讯作者:
    Undrovinas, Albertas
Increased sensitivity to local anesthetic drugs: bedside to bench.
对局部麻醉药物的敏感性增加:从床边到工作台。
  • DOI:
    10.1161/circresaha.108.182055
  • 发表时间:
    2008
  • 期刊:
  • 影响因子:
    20.1
  • 作者:
    Fozzard,HarryA
  • 通讯作者:
    Fozzard,HarryA
Electrostatic and steric contributions to block of the skeletal muscle sodium channel by mu-conotoxin.
  • DOI:
    10.1085/jgp.119.1.45
  • 发表时间:
    2002-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Hui K;Lipkind G;Fozzard HA;French RJ
  • 通讯作者:
    French RJ
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DOROTHY A. HANCK其他文献

DOROTHY A. HANCK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DOROTHY A. HANCK', 18)}}的其他基金

Drug therapy targeted to the voltage-gated sodium channel
针对电压门控钠通道的药物治疗
  • 批准号:
    7682803
  • 财政年份:
    2009
  • 资助金额:
    $ 36.15万
  • 项目类别:
Cardiac Channels: Targets of Drugs that Affect Kinetics
心经:影响动力学的药物靶点
  • 批准号:
    7822235
  • 财政年份:
    2009
  • 资助金额:
    $ 36.15万
  • 项目类别:
Drug therapy targeted to the voltage-gated sodium channel
针对电压门控钠通道的药物治疗
  • 批准号:
    7923976
  • 财政年份:
    2009
  • 资助金额:
    $ 36.15万
  • 项目类别:
STRUCTURAL BASES OF T-TYPE CALCIUM CHANNEL FUNCTION
T型钙通道功能的结构基础
  • 批准号:
    6648432
  • 财政年份:
    2000
  • 资助金额:
    $ 36.15万
  • 项目类别:
CARDIAC CHANNELS--TARGETS OF DRUGS THAT AFFECT KINETICS
心脏通道——影响动力学的药物靶标
  • 批准号:
    6651146
  • 财政年份:
    2000
  • 资助金额:
    $ 36.15万
  • 项目类别:
Cardiac Channels: Targets of Drugs that Affect Kinetics
心经:影响动力学的药物靶点
  • 批准号:
    7356037
  • 财政年份:
    2000
  • 资助金额:
    $ 36.15万
  • 项目类别:
CARDIAC CHANNELS--TARGETS OF DRUGS THAT AFFECT KINETICS
心脏通道——影响动力学的药物靶标
  • 批准号:
    6390884
  • 财政年份:
    2000
  • 资助金额:
    $ 36.15万
  • 项目类别:
CARDIAC CHANNELS--TARGETS OF DRUGS THAT AFFECT KINETICS
心脏通道——影响动力学的药物靶点
  • 批准号:
    6527645
  • 财政年份:
    2000
  • 资助金额:
    $ 36.15万
  • 项目类别:
CARDIAC CHANNELS--TARGETS OF DRUGS THAT AFFECT KINETICS
心脏通道——影响动力学的药物靶标
  • 批准号:
    6191525
  • 财政年份:
    2000
  • 资助金额:
    $ 36.15万
  • 项目类别:
STRUCTURAL BASES OF T-TYPE CALCIUM CHANNEL FUNCTION
T型钙通道功能的结构基础
  • 批准号:
    6700442
  • 财政年份:
    2000
  • 资助金额:
    $ 36.15万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 36.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 36.15万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 36.15万
  • 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 36.15万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 36.15万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 36.15万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 36.15万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 36.15万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 36.15万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 36.15万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了